Colombian consensus recommendations for diagnosis, management and treatment of the infection by SARS-COV-2/ COVID-19 in health care facilities - Recommendations from expert´s group based and informed on evidence

La Asociación Colombiana de Infectología (ACIN) y el Instituto de Evaluación de Nuevas Tecnologías de la Salud (IETS) conformó un grupo de trabajo para desarrollar recomendaciones informadas y basadas en evidencia, por consenso de expertos para la atención, diagnóstico y manejo de casos de Covid 19. Estas guías son dirigidas al personal de salud y buscar dar recomendaciones en los ámbitos de la atención en salud de los casos de Covid-19, en el contexto nacional de Colombia

A first attempt of acoustically assessing the shallow waters (<20 m depth) off the Gulf of Cadiz (ICES Subdivision IXa South): the ECOCÁDIZ-COSTA 0709 Spanish Survey (July 2009).

The present working document summarises the main results from one IEO’s coastal (50 – 7 m depth) survey (ECOCÁDIZ-COSTA 0709) complementary and almost synchronous (2nd-9thJuly 2009, R/VFrancisco de Paula Navarro) to the Spanish “standard” acoustic (pelagic ecosystem-) survey (ECOCÁDIZ 0609; 27thJune-6th July 2009; Portuguese and Spanish shelf waters off the Gulf of Cadiz: 20-200 m isobaths; R/V Cornide de Saavedra). Unfortunately, the impossibility of fishing in waters deeper than 25 m depth with an appropiate gear resulted in a relatively high percentage (51.5%) of Not Identified NASCs in relation to the total sampled back-scattering energy attributed to fish, although these energies were mainly concentrated in the deepest ESDUs previously sampled and assessed by the conventional survey. Acoustic energies in the coastal survey were not very high in the shallower waters, which is reflected in the contribution to the total energy by the most coastal species.Versión del edito

Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE REPRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care